再鼎醫藥(09688.HK)公布根據美國公認會計準則編製截至去年12月底止全年業績，營業額2.67億美元(下同)，按年升24%。虧損淨額收窄至3.35億元，上年同期蝕4.43億元；每股虧損0.35元。不派息。
《公司業績》再鼎醫藥(09688.HK)全年虧損收窄至3.35億美元 不派息
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.